(Q36716328)

15 August 2017

title

Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach (English)

1 reference

15 August 2017

1 reference

R E Port

1

1 reference

15 August 2017

H P Schlemmer

series ordinal

2

1 reference

15 August 2017

P Bachert

series ordinal

3

1 reference

15 August 2017

publication date

1 January 1994

1 reference

European Journal of Clinical Pharmacology

15 August 2017

published in

1 reference

15 August 2017

volume

47

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

187-193

1 reference

In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.

15 August 2017

cites work

1 reference

12 December 2020

Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumors

1 reference

12 December 2020

Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14

1 reference

12 December 2020

Relative importance of dose, body surface area, sex, and age for 5-fluorouracil clearance

1 reference

12 December 2020

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

1 reference

12 December 2020

Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients

1 reference

12 December 2020

Population pharmacokinetics. Theory and clinical application

1 reference

12 December 2020

Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment

1 reference

12 December 2020

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1 reference

12 December 2020

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

12 December 2020

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits

1 reference

12 December 2020

Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy

1 reference

12 December 2020

Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma

1 reference

12 December 2020

Modelling of individual pharmacokinetics for computer-aided drug dosage

1 reference

12 December 2020

Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Population Pharmacokinetics/Dynamics*

1 reference

12 December 2020

New strategies in drug development and clinical evaluation: the population approach. Commentary on an action for co-operative research

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194971

1 reference

15 August 2017

1 reference